Repligen Corp [RGEN] stock prices are up 3.62% to $164.74 at the moment. One of the good ways to gauge the recent performance is if the stock’s short-term value is rising or falling. The RGEN shares have gain 12.13% over the last week, with a monthly amount drifted -1.88%, and not seem to be holding up well over a long-time horizon.
From an analyst’s perspective:
Repligen Corp [NASDAQ: RGEN] stock has seen the most recent analyst activity on February 10, 2025, when TD Cowen initiated its Buy rating and assigned the stock a price target of $200. Previously, Canaccord Genuity started tracking the stock with Hold rating on December 17, 2024, and set its price target to $165. On November 14, 2024, Wolfe Research initiated with a Peer Perform rating. Wells Fargo started tracking the stock assigning a Overweight rating and suggested a price target of $180 on August 28, 2024. Deutsche Bank upgraded its rating to a Buy and reduced its price target to $155 on June 26, 2024. In a note dated December 04, 2023, The Benchmark Company downgraded an Hold rating on this stock.
The stock price of Repligen Corp [RGEN] has been fluctuating between $113.50 and $203.13 over the past year. Currently, Wall Street analysts expect the stock to reach $220 within the next 12 months. Repligen Corp [NASDAQ: RGEN] shares were valued at $164.74 at the most recent close of the market. An investor can expect a potential return of 33.54% based on the average RGEN price forecast.
Analyzing the RGEN fundamentals
The Repligen Corp [NASDAQ:RGEN] reported sales of 634.44M for trailing twelve months, representing a surge of 0.56%. Gross Profit Margin for this corporation currently stands at 0.47% with Operating Profit Margin at -0.01%, Pretax Profit Margin comes in at -0.0%, and Net Profit Margin reading is -0.03%. To continue investigating profitability, this company’s Return on Assets is posted at -0.01, Equity is -0.01 and Total Capital is -0.0. An extended analysis of the company’s primary financial structure reveals a debt-to-equity ratio of0.33.
Before buying any particular stock, readers tend to pay close attention to the indicators that support and create resistance. The company’s stock is currently sitting at 158.88 points at the first support level, and at 153.02 for the second support level. However, for the 1st resistance point, the stock is sitting at 169.35, and for the 2nd resistance point, it is at 173.95.
Ratios To Look Out For
It’s worth pointing out that Repligen Corp [NASDAQ:RGEN]’s Current Ratio is 10.44. Also, the Quick Ratio is 8.76, while the Cash Ratio stands at 7.23. Considering the valuation of this stock, the price to sales ratio is 14.55, the price to book ratio is 4.58.
Transactions by insiders
Recent insider trading involved Hunt Anthony, Director, that happened on Nov 21 ’24 when 24246.0 shares were sold. Executive Chairman, Anthony Hunt completed a deal on Nov 21 ’24 to buy 24246.0 shares. Meanwhile, Director Hunt Anthony sold 22191.0 shares on Sep 10 ’24.
